Widespread decrease in local cerebral glucose utilization (LCGU) previously shown to occur 3 days af ter a focal freezing lesion was interpreted as reflecting a depression of functional activity in the affected areas. In parallel experiments, cortical norepinephrine (NE) con tent of traumatized brain was found to be decreased. The effects of prazosin (PZ), an Ci [-adrenergic receptor blocker, and yohimbine (YOH), an Ci2-blocker, on glu cose use and biogenic amine content of lesioned rat brain were studied to determine if the changes in the noradre nergic system associated with injury are of functional im portance, to identify the receptors that may be involved in mediating the action of N E in injured brain, and to look for evidence of interaction between the noradrenergic and the serotonergic systems in traumatized brain. PZ (I mg/ kg) given 30 min before the lesion ameliorated the subse quent metabolic cortical depression seen in untreated an imals. PZ given for 3 days starting before the lesion (3 mg/kg/day) was also effective in normalizing LCGU in areas where it was depressed by lesioning, despite the fact that this regimen induced significant global decrease in LCGU in normal animals. Once cortical metabolic de-A focal cortical freezing lesion in the rat was used as a model of cerebral injury in a series of studies (Pappius, 198 
pression had developed 3 days after the lesion, it could not be modified by PZ. YOH was less effective than PZ and was so only when given for 3 days (22.5 mg/kglday in three divided doses). PZ (3 mg/kg/day in three divided doses) slightly but significantly decreased the accumula tion of the serotonin (5-HT) metabolite 5-hydroxyin doleacetic acid in the traumatized hemisphere. These re sults provide evidence that blockage of Ci[-adrenergic re ceptors prevents the development of cortical dysfunction associated with brain trauma. This implies that the nor adrenergic system plays a role in the functional conse quences of injury and that this effect is, at least in part, mediated by Ci [-adrenergic receptors. Furthermore, Ci) adrenergic receptor blockage appears to modulate corti cal turnover of 5-HT, previously also implicated in func tional consequences of brain injury. The data are com patible with inhibitory effects of NE in the cortex and suggest a potential of Ci)-adrenergic blockage in develop ment of novel therapeutic approaches to brain injury. Key Words: Brain injury-Local cerebral glucose utilization Norepinephrine-Prazosin-Yohimbine. Pappius et al. , 1988) in which the functional state of traumatized brain was assessed with the deoxyglu cose (DG) method (Sokoloff et al., 1977; Sokoloff, 198 1) for determination of local cerebral glucose uti lization (LCGU). Pharmacological manipUlations were employed to shed light on possible mecha nisms mediating neurological dysfunction resulting from brain trauma. A widespread depression was shown to develop with time after the lesion through out the cortical areas of the lesioned hemisphere, with the average cortical LCGU approaching 50% of normal 3 days after the lesion. The depression of glucose utilization was interpreted as a manifesta tion of cerebral dysfunction, since in the absence of parallel alterations in cortical blood flow, there was no evidence that the changes in LCGU represented metabolic effects of diminished blood supply. It is envisaged that the energy needs of cortical areas in the injured brain are diminished because of a func tional depression in the affected regions. The find ing of somatosensory deficits that were significantly correlated with the extent of the cortical depression of glucose utilization in traumatized hemisphere (Colle et aI., 1986 ) supports this hypothesis, as does the demonstration that the effects of anesthetics in metabolically depressed regions are limited by the decrease in LCGU that has already occurred due to the lesion (Archer et al., 1990) .
The development of widespread cortical meta bolic depression in rats with focal freezing lesions has been independently confirmed (Gaab et aI., 1987; Contreras et aI., 1988) . More recently reduced local CMR g \c was described in ipsilateral cortical regions 5 days following a photochemically induced lesion in the frontal cortex of the rat (Ginsberg et aI., 1989) . Furthermore, in this elegant study, a sup pression of normal physiological activation in the remote ipsilateral structures in the injured brain was also clearly demonstrated.
It is of particular interest that in head-injured pa tients studied by positron emission tomography, disturbances of glucose metabolism extending be yond abnormalities demonstrated by magnetic res onance and computed tomography and not accom panied by alterations in regional CBF have been reported (Langfitt et al., 1986) .
Subsequent studies Dadoun, 1986, 1987) showed that a freezing lesion in the rat in duced an increase in serotonin (5-HT) metabolism in the cortex of the lesioned hemisphere, as well as a depression in cortical norepinephrine (NE) con tent bilaterally, but no changes in cortical dopamine and its metabolites. The finding that the depressed state of the lesioned brain, as assessed by metabolic mapping with the DG method, could be ameliorated by inhibition of 5-HT synthesis with p-chloro phenylalanine (PCPA) (Pappius et aI., 1988) pro vided strong evidence that the activation of 5-HT metabolism throughout the cortex of focally injured hemisphere is of functional significance. Such a conclusion is compatible with the postulated inhib itory nature of 5-HT action on cortical neuronal ac tivity (Bloom et aI., 1972; Sastry and Phillis, 1977; Taylor and Stone, 198 1) .
The present studies were designed to establish whether the previously demonstrated changes in cortical NE content (Pappius and Dadoun, 1986) were also of functional significance, to identify the receptors that may be involved in mediating the ac tion of NE in injured brain, and to look for evidence in lesioned brain of interactions, well documented in normal brain (e.g., Kostowski et aI., 1974; Saave dra et aI., 1976; Pujol, 1979; Pujol et aI., 198 1; Agren et aI., 1986; Brassard et aI., 1987) , between the noradrenergic locus ceruleus (LC) and the se rotonergic raphe systems.
MATERIALS AND METHODS

General procedure
Small freezing lesions standardized to produce super ficial focal cortical injury in the rat were made in the left parietal region of halothane-anesthetized male Sprague Dawley rats (300--325 g) by applying a freezing probe (di ameter 4 mm) cooled to -50°C for 5 s to the exposed dura. After the lesion was made, the wound was sutured and the animals allowed to awaken. At specified intervals after the lesion, either a r l4 CjDG study was carried out as described below or the animal was decapitated and the brain processed for analysis of NE, 5-HT, and 5hydroxyindoleacetic acid (5-HIAA) according to proce dures indicated below. The animals were maintained in a temperature-and light-controlled environment through out and were always killed at the same time of day (for biogenic amine analysis II :00 a. m. ± 30 min; for LCGU determination between I :00 and 3:00 p.m.).
The physiological state of the conscious fasted animals destined for LCGU determination was assessed by mon itoring arterial blood pressure and rectal temperature and by measurement of the hematocrit, serum glucose, and blood gases prior to the DG study. It was assumed that animals decapitated for biogenic amine analysis were in a similar physiological condition.
Plasma glucose concentration was measured by means of YSI glucose analyzer (model 23A; Yellow Springs In struments, Yellow Springs, OH, U. S.A.) and plasma r I4 C]DG content was determined in a liquid scintillation counter (model 1219, LKB, Rackbeta liquid scintillation counter; Allied Scientific Ltd., Montreal, Quebec, Can ada). Blood gases were determined with a micro blood gas analyzer (model 175; Corning, Boston, MA, U. S.A.).
Determination of LCGU
In the present experiments, LCGU was measured 3 days after the lesion was made. This time period was chosen because at that point the depression of cortical glucose utilization is most pronounced in untreated le sioned animals. LCGU was determined using the [ 14 C]DG quantitative radioautographic method of Soko loff et al. (\ 977) . Briefly, under general anesthesia with 2% halothane in oxygen and spontaneous respiration, polyethylene catheters were placed in the femoral artery and femoral vein. The animals were restrained from the waist down in a loosely applied plaster cast and allowed to recover from anesthesia for at least 3 h.
After physiologic parameters were determined to be within normal limits, the LCGU experiment was begun by injecting a bolus of 30 j.LCi of [ 14 C]DG (2-deoxY-D-[1-14 C] glucose, specific activity, 50--56 j.LCi/mmol; New England Nuclear) into the venous catheter over 30 s. Timed arte rial sampling for determination of plasma [ 14 C]DG and glucose concentrations commenced at the start of injection and was continued for 45 min. The animals were then killed by decapitation, and the brain was quickly removed and frozen in Freon XII, cooled at -50 to -60°C in liquid nitrogen Vapor. Brains were sectioned into 20-loLm-thick slices in. a cryostat (American Optical Co., Buffalo, NY, U.S.A.) maintained at -22°C. The dried sections were used to prepare autoradiographs. Cal ibrated [14C]methylmethacrylate standards (New Eng land Nuclear) were included with each autoradiograph. Densitometry was performed on the developed autoradio graphs with a Photo volt Densitometer (model 52; Photo volt Corp., New York, NY, U.S.A.), using a O.I-mm ap erture and averaging the results of at least five readings from each structure studied. Calculation of LCGU was accomplished using a computer program written for a PDP-12 computer (Digital Equipment Corp., Maynard, MA, U.S.A.).
As in previous studies LCGU was measured in 27 structures and areas. However, only representative re sults from non cortical structures are given in the tables since the effects of injury and of the drugs used were most pronounced in cortical areas.
Determination of NE, 5-HT, and 5-HIAA content in cerebral cortex and raphe nucleus NE, 5-HT, 5-HIAA were determined in cerebral cortex tissue and raphe nucleus in untreated and treated animals on days 1 and 3 postlesion. Cortical tissue samples were hand-dissected at room temperature from the brain quickly removed from the skull following decapitation, as previously described (Pappius and Dadoun, 1987) . The frontoparietal cortex samples (150-200 mg), free of un derlying white matter from which the lesion area was al ways discarded, were rapidly frozen in liquid nitrogen, weighed with care being taken that no thawing occurred, and rapidly homogenized (sonic dismembrator; Artex System Corp., Farmingdale, NY, U.S.A.) in 0.5 ml of ice-cold 0.3 M perchloric acid containing 150 pmol of di hydroxybenzylamine (DHBA) as internal standard. The homogenates were centrifuged at 15,000 rpm at 4°C for IS min. Supernatants were stored at -80°C and thawed just before analysis.
To obtain "raphe area" samples, the cerebellum was removed first and a transverse section made at an angle passing rostrally to the midbrain raphe nuclei region fol lowed by a second cut through the caudal medulla at the level of the obex. Then the raphe area was dissected from the brainstem by two parasagittal cuts I mm lateral from the midline and divided along the midline. Thus, each sample contained serotonergic cell bodies with both as cending and descending projections. The weight of each unilateral sample was always between 20 and 30 mg. They were weighed after freezing in liquid nitrogen and ex tracted in 200 loLl of 0.3 M perchloric acid containing ISO pmol DHBA as internal standard (Mefford, 1981) .
The chromatography analyses were performed with a high performance liquid chromatograph equipped with a pump (model 590; Waters Associates, Milford, MA, U.S.A.), an automatic injector (WISP 71OB; Waters As soc.), an integrator (data module 730; Waters Assoc.), and a model LC-4B (Bioanalytical Systems) glassy car bon (TL3) amperometric detector.
In a procedure adapted from Warn hoff (1984), a S-loLm CI8 RCM 100 column (inner diameter 8 mm) protected by a Guard Pak precolumn module (Waters Assoc.) was 1991 used. The mobile phase, consisting of 0.1 M sodium ac etate, 0.1 M citric acid, 15% (vol/vol) methanol, and SOO IoLIIL of N-dibutylamine (pH 4.7), was pumped at a flow rate of 0.6 ml/min. The detector potential was set at 0.70 V vs. Ag/AgCl reference electrode. The standard stock solution contained 100 IoLg/ml H20 of the following: 5hydroxytryptamine hydrochloride, S-hydroxyindoleace tic acid hydrochloride, and DHBA (internal standard), all from Sigma Chemical Co. (St. Louis, MO, U.S.A.). The stock solution was stored at -80°C. Aliquots were thawed and diluted 1: I ,000 daily.
This procedure gave excellent resolution of the 5-HT, 5-HIAA, and DHBA peaks in all samples and of NE in supernatants from raphe nucleus. For determination of NE in cerebral cortex, the run was repeated with a mod ified mobile phase (S% methano1l3S0 fl.1 DHBAlL) to al low better separation of the NE peak from the solvent front peak.
Drug doses and regimen
Prazosin (PZ), an !X)-adrenergic receptor blocker, and yohimbine (YaH), an !X2-adrenergic receptor blocker, were each given in three different regimens to answer three specific questions.
To determine whether these drugs modulated glucose use in injured brain at the height of the cortical depression of LCGU, the drug was injected once 30 min before the DG study on the third postlesion day. These groups are designated PZ-treated 30 min and YaH-treated 30 min.
To establish if adrenergic receptor blockage could pre vent the development of the cortical metabolic depres sion, the drugs were given once 30 min before the lesion was made (i.e., on day 0). These groups are designated PZ-and YaH-treated prelesion.
To define maximum effects of the drugs, each was given three times per day starting twice on day 0 before the lesion was made and continuing for a total of 3 days (i.e., including postlesion day 2). No injection was given on the day of the DG study (postlesion day 3) to avoid potential short-term effects of adrenergic receptor block age. These are the PZ-and YaH-treated 3-day groups.
Both drugs were given intraperitoneally in I ml saline: PZ I mg (2.39 fl.mol)/kg and YaH 7.S mg (19.19 fl.mol)/kg. Thus, the daily doses in the 3-day groups were 3 (7.16) and 22.5 mg (57.S6 fl.mol)/kg/day, respectively.
In control experiments the drugs were administered to unlesioned animals in doses and regimen corresponding to the experimental groups. For determination of biogenic amines, the animals were killed either on day I or day 3 postlesion after multiple injections as described for the treated 3-day groups. The drug was not administered on the day the animals were decapitated.
Statistical analysis
The Bonferroni procedure (two tailed) for simultaneous multiple comparisons was used for determination of sta tistical significance between groups (Wallenstein et aI., 1980) .
RESULTS
Physiological state of the animals
The values obtained for the measured variables in 21 normal animals before the start of the DG study were as follows (average ± SD): mean arterial blood pressure, 127 ± 10 mm Hg; rectal tempera ture, 36. 1 ± O.4°C; glucose, 139 ± 18 mg/dl; P a02 95 ± 9 mm Hg; Paco2, 40.6 ± 2.6 mm Hg; pH, 7.4 1 ± 0.03; hematocrit, 50 ± 1%. As previously shown (Pappius, 198 1), a cortical freezing lesion did not significantly affect any of the measured physiolog ical variables.
In the treated animals most physiological param eters were within normal limits. However, when PZ was given 30 min before the DG study, the average arterial blood pressure fell to 96 ± 15 mm Hg (11 animals, pooled control and lesioned), while 30 min after YOH arterial blood pressure was 95 ± 15 mm Hg and Paco2 was 37.6 ± 3.6 mm Hg (14 animals).
Effects of PZ on LCGU in intact brain (Table 1) PZ given in a single dose (I mg/kg) 30 min before the DG study (30-min group) had no effect on LCGU in any of the structures studied. When it was given 3 days before the determination of glucose utilization (prelesion group), to correspond to be fore the lesion in lesioned animals, a slight increase in LCGU was noted in a few subcortical structures. In contrast, when PZ was given for 3 days before, but not on, the day of the DG study (3-day group), LCGU was significantly depressed in all cortical areas and in a majority of subcortical structures. In brainstem structures the decrease in LCG U after repeated doses of PZ did not reach statistical sig nificance.
Effects of PZ on LCGU in lesioned brain (Table 2) In untreated animals 3 days following a focal freezing lesion in the parietal cortex, LCGU in the lesioned hemisphere was essentially as shown pre viously. In cortical areas it was severely depressed, with average cortical glucose utilization at 47% of normal. In subcortical structures the depression was less marked (in structures listed in Table 2 : 76% of normal). In contrast to previous series where brainstem structures were not affected, in the present experiments LCGU in these was also sig nificantly though much less decreased (86% of nor mal). PZ (I mg/kg) given 3 days after the freezing lesion, 30 min before the DG study (30-min group), did not modify the depression of LCGU induced in the lesioned hemisphere by the traumatization. In contrast, the same single dose of PZ given 30 min before the lesion was made, 3 days before the DG study (prelesion group), significantly ameliorated the depression of LCG U in all areas and structures in which it was depressed by lesioning. PZ given three times for 3 days (3 mg/kg/day), starting before the lesion was made (3-day group), was also effec tive: In most areas and structures of the lesioned hemisphere, LCGU was significantly increased as compared with untreated animals.
In the hemisphere contralateral to the lesion, as shown previously, in untreated animals cortical LCGU was somewhat depressed (83% of normal) but much less so than in the lesioned hemisphere, as Values are means ± SO, expressed as tJ-mol/lOO g/min, n = no. of animals.
o PZ was given as a single dose (l mg/kg) 30 min before LCaU determination. b PZ was given as a single dose (l mg/kg) 3 days before LCaU determination to correspond to prelesion group of traumatized animals.
" PZ was given for 3 days before LCaU determination in three divided doses (3 mg/kg / day) . d Significantly different from normal, p < 0.01. e Significantly different from normal, p < 0.05 . Values are means ± SO, expressed as f.1,mol/I OO g/min, n = no. of animal s, FL3d, 3 days following focal freezing lesion, a PZ was given as a single dose (I mg/kg) 3 days after lesioning. 30 min before LCG U determination, b PZ was given as a single dose (I mg/kg) 30 min before lesioning, 3 days before LCG U determination, C PZ was given for 3 days before LC GU determination in three divided doses (3 mg/kg/day) starting before the lesion was made . d Significantly different from normal (data in was LCGU in the majority of subcortical and brain stem structures (87 and 87% of normal, respec tively). These effects of injury were ameliorated by PZ given as a single I-mg/kg dose before the lesion was made. The repeated dose regimen of PZ (3 mg/ kg/day) increased LCGU in all areas and structures of the contralateral hemisphere to normal range, in some instances to levels significantly higher than in the corresponding unlesioned controls ( Table 1) .
Effects of YOH on LCGU in intact brain ( Table 3) In normal animals, YOH given 30 min before the DG study (30-min group) caused an average 30% decrease in glucose utilization in all structures in which it was measured. YOH had no effect when given as a single dose 3 days earlier (prelesion J Cereb Blood Flow Metab, Vol, 11, No, 2, 1991 group), or when given for 3 days before but not on the day of determination of LCGU (3-day group).
Effects of YOH on LCGU in lesioned brain (Table 4) In animals with a cortical freezing lesion, YOH did not modify the depression of LCGU seen 3 days after the lesion in untreated animals when given as a single dose (7.5 mg/kg) 30 min before the lesion was made (prelesion group) or 30 min before the DG study (30-min group). However, in the latter group there was no further depression of LCGU as com pared with untreated controls, which was seen when the drug was given in intact animals (Table 3) . YOH given for 3 days starting before the lesion was made in three divided doses (22. 5 mg/kg/day) Values are means ± SD, expressed as f.Lmol/IOO g/min, n = no. of animals.
a YOH was given as a single dose (7.5 mg/kg) 30 min before LCGU determination. b YOH was given as a single dose (7.5 mg/kg) 3 days before LCGU determination to correspond to prelesion group of traumatized animals.
C YOH was given for 3 days before LC GU determination in three divided do ses (22.5 mg/kg/day) . d Signific antly diffe rent from normal, p < 0.0 I. e Significantly diffe rent from normal, p < 0.05.
significantly increased cortical LCGU in the le sioned hemisphere except for the regions surround ing the lesion area (parietal cortex). YOH, how ever, was much less effective than PZ and the rates of cortical glucose utilization did not approach nor mal levels.
Effect of PZ and YOH on biogenic amines in intact and traumatized brain (Table 5) In intact brain the two adrenergic blockers in the dose and regimen used had only a minimal effect. Three days of treatment with PZ lowered modestly but significantly the 5-HT content of the cortex without, however, affecting the level of the metab olite 5-HIAA, while YOH induced a transient de crease in cortical 5-HIAA and NE levels. In the lesioned hemisphere, as shown previously Dadoun, 1986, 1987; Pappius et aI., 1988) , cor tical 5-HIAA was significantly increased on both days 1 and 3 postlesion, while NE content was de creased, and both indoleamines and NE were in creased in the raphe area. In PZ-treated lesioned animals, the increase in cortical 5-HIAA was slightly diminished, significantly so on day I. YOH had no effect in the cortex, and neither drug modi fied the changes in indoleamines and NE in the ra phe area.
DISCUSSION
PZ is thought to be a specific NE antagonist at the postsynaptic ai-adrenergic receptors (Miach et aI., 1980; Weiner, 1980) . Thus, the major conclusion from the present work is that the blockage of these receptors appears to prevent the development of cortical dysfunction associated with brain trauma. This implies that the noradrenergic system plays a role in the functional consequences of brain injury and that this effect is, at least in part, mediated by a I-adrenergic receptors.
The decrease in LCGU in the lesioned hemi sphere, which we interpret as reflecting a depres sion of integrated cortical function (Pappius, 198 1; Pappius and Wolfe, 1986) , develops with time and reaches its peak 3 days after the freezing lesion. PZ given 30 min before lesioning, in a single dose (1 mg/kg) that was without effect in normal animals, significantly improved glucose utilization 3 days later in all cortical regions as well as in those sub cortical structures that were affected by the injury in untreated animals. PZ (3 mg/kg/day) continued for 2 days after the lesion also produced normaliza tion of the depressed glucose utilization in the af fected regions, despite the fact that this regimen induced significant global decrease in LCGU in nor mal animals. In contrast, PZ (1 mg/kg) given acutely 3 days after the lesion and 30 min before the DG study was without effect on LCGU in traumatized brain. Thus, once it develops, the cortical depres sion does not appear to be modified by ai-adre nergic blockade, at least at the dose of PZ used in these studies.
Cerebral cortex, in our studies the area most af- Values are means ± SD, expressed as IJ-mol/IOO g/min, n = no. of animals. FL3d, 3 days following focal freezing lesion.
a YOH was given as a single dose (7.5 mg/kg) 3 days after lesioning, 30 min before LCGU determination. b YOH was given as a single dose (7.5 mg/kg) 30 min before lesioning, 3 days before LC GU determination.
C YOH was given for 3 days before LC GU determ ination in three divided doses (22.5 mg/kg/day) starting before the lesion was made . d Significantly different from normal (data in fected by traumatization, is widely innervated by noradrenergic fibers arising from the nucleus LC (e.g., Foote and Morrison, 1987; Aston-Jones et ai., 1990) . Laminar distribution of O'}-adrenergic recep tors throughout the rat cortex has been demon strated in vitro (Jones et aI., 1985; Palacios et ai., 1987) and in vivo (Dyve et ai., 1989 , 1990) . Only when circuits and signals that in turn influence these two nuclei have been elucidated will it be possible to speculate on the most likely polysynaptic pathways responsi ble for inducing changes in the noradrenergic sys tem in injured brain. YOH, usually considered to be an O'radrenergic 
data are compatible with the inhibitory effects in the cortex of both 5-HT and NE (Bloom et a!., 1972; Sastry and Phillis, 1977; Taylor and Stone, 198 1; Waterhouse et a!., 1982; Mantz et a!., 1988) and with the hypothesis that these two transmitter sys tems affect cortical information processing (Fallon and Loughlin, 1987; Foote and Morrison, 1987) . Widespread metabolic depression similar to that obtained in our model has been reported following unilateral ablation of sensorimotor cortex in rats and interpreted within the context of von Mona kow's theory of diaschisis (Feeney et a!., 1985; Feeney and Baron, 1986; Feeney and Sutton, 1988) .
In apparent contrast to our results, these authors found that after cortical injury, catecholamine acti vation with amphetamine alleviated what they call the metabolic remote functional depression, which was accelerated by LC lesions and exacerbated by catecholamine blockade with haloperidol. Since drugs affecting primarily the dopamine system (e.g., apomorphine) did not have any effect on the remote metabolic changes or on behavioral deficits in their animals, Feeney et al. concluded that NE must be involved in recovery of function after sen sorimotor cortex injury, whereas we believe that NE mediates development of functional disturb ances. The discrepancies between these two sets of results are unlikely to be explained only by our use of a more specific adrenergic blocker. Rather, dif ferences in size and location of the lesions and their behavioral effects must be considered. The rats of Feeney et ai. were hemiplegic; ours were not. Fur thermore, in our studies the degree and extent of the metabolic depression were independent of the exact location of the lesion, and while decreases in turning wheel activity and difficulties with limb co ordination were demonstrated, only the asymme tries in somatosensory responsiveness could be cor related with the widespread decrease in cortical LCGU (Colle et aI., 1986) . Thus, the superficial, spatially nonspecific cortical freezing lesion we use may represent a model of disturbances limited to cortical information processing.
A recent report that clonidine impairs recovery of beam walking after a sensorimotor cortex lesion in the rat (Goldstein and Davis, 1990 ) is in agreement with the conclusion that the noradrenergic system plays a role in functional consequences of brain in jury, but, in contrast to the present study, media tion by <X2-rather than <Xl-adrenergic receptors is implied. Again, differences in the severity and lo cation of the lesion may account for the discrep ancy. It may be pertinent to this discussion that controversy also exists about the role of the norad renergic system in the consequences of ischemia, J Cereb Blood Flow Metab, Vol. JI, No.2, 1991 with release of NE considered as protective for brain recovery by some (Blomqvist et a!., 1985; Koide et aI., 1986; Araki et a!., 1989; Miyauchi et aI., 1989) and deleterious by others (Busto et aI., 1985) .
Although the exact mechanisms and pathways by which noradrenergic innervation contributes to neurological disturbances associated with cortical lesions are not known, our work represents a novel approach to problems of brain injury, with a poten tial for developing new rational modes of therapy particularly attractive inasmuch as drugs already in wide use may turn out to be useful clinically in head trauma.
